Before even presenting a slide or delivering a well-rehearsed opening line, investors are already forming opinions. Having supported numerous early-stage startups, including a successful €50 million Series B round, it’s clear that investors often judge long before the numbers are shown. They assess the founder’s authenticity and understanding of their business’s intricacies. Key factors include whether the founder is genuinely engaged or merely polished, their awareness of operational vulnerabilities, and their understanding of the market and procurement processes. Consistency between the pitch and actual decision-making is crucial, as is the ability to admit unknowns. Investors seek founders who can handle pressure, adapt, and remain honest. In high-stakes sectors like FoodTech and MedTech, where regulations are stringent, this awareness is essential. Before perfecting the pitch, founders should consider how they would evaluate themselves if they were the investors.
What crucial lessons does a €50 million Series B offer for all startup funding stages?
